Business

KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress

MAHWAH, N.J., May 18, 2026--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company presented its latest research at the Oncology Nursing Society (ONS) Congress, May 13-17. The poster at ONS was titled, "Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration."

articleKoru Medical Systems, Inc.May 18, 20263/company/repro-med-systems-inc/news/koru-medical-systems-presents-real-world-data-on-the-benefits-of-the-freedomedge-syringe-infusion-system-in-infusion-clinics-at-the-51st-annual-oncology-nursing-society-congress
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress

About this update from Koru Medical Systems, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/8715bd94eca5ac98e21d96bacfbd2e2b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/U3Nj8Q8BxC4B.23WYSK6Eg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/8715bd94eca5ac98e21d96bacfbd2e2b","width":960,"height":480},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/OGvio46ut_rNZWKeqrd4xw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMyMA--/https://media.zenfs.com/en/business-wire.com/8715bd94eca5ac98e21d96bacfbd2e2b","width":640,"height":320},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/asSV_UtbMLpkHfJW9glHuA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/8715bd94eca5ac98e21d96bacfbd2e2b","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MAHWAH, N.J., May 18, 2026--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company presented its latest research at the Oncology Nursing Society (ONS) Congress, May 13-17. The poster at ONS was titled, "Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration."","length":512,"tagName":"p"},{"type":"text","content":"The ONS abstract evaluated nursing workflow, nurse experience, and patient-reported outcomes after implementing KORU Medical's FreedomEDGE® infusion system for subcutaneous drug administration across four community infusion centers in the United States. The findings demonstrated:","length":284,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Efficiency- 100% of doses successfully administered with infusion times aligned with clinical guidelines","length":104,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Reduced Strain- Nurses experienced significantly less strain after implementing pump assisted or tubing-needle set assisted drug administration","length":143,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"High Satisfaction- Both nurses (4.85/5) and patients (4.92/5) reported high ...

More updates from Koru Medical Systems, Inc.

Oncology Nursing SocietyFreedom SystemKORU Medicalsubcutaneous infusionpatient outcomesdrug administrationONSKORU Medical Systems, Inc.research findingsKORU Medical Systems